Cargando…

Tailored Implementation for Chronic Diseases (TICD): a protocol for process evaluation in cluster randomized controlled trials in five European countries

BACKGROUND: In the ‘Tailored Implementation for Chronic Diseases (TICD)’ project, five tailored implementation programs to improve healthcare delivery in different chronic conditions have been developed. These programs will be evaluated in distinct cluster-randomized controlled trials. This protocol...

Descripción completa

Detalles Bibliográficos
Autores principales: Jäger, Cornelia, Freund, Tobias, Steinhäuser, Jost, Aakhus, Eivind, Flottorp, Signe, Godycki-Cwirko, Maciek, van Lieshout, Jan, Krause, Jane, Szecsenyi, Joachim, Wensing, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994491/
https://www.ncbi.nlm.nih.gov/pubmed/24655439
http://dx.doi.org/10.1186/1745-6215-15-87
_version_ 1782312736957399040
author Jäger, Cornelia
Freund, Tobias
Steinhäuser, Jost
Aakhus, Eivind
Flottorp, Signe
Godycki-Cwirko, Maciek
van Lieshout, Jan
Krause, Jane
Szecsenyi, Joachim
Wensing, Michel
author_facet Jäger, Cornelia
Freund, Tobias
Steinhäuser, Jost
Aakhus, Eivind
Flottorp, Signe
Godycki-Cwirko, Maciek
van Lieshout, Jan
Krause, Jane
Szecsenyi, Joachim
Wensing, Michel
author_sort Jäger, Cornelia
collection PubMed
description BACKGROUND: In the ‘Tailored Implementation for Chronic Diseases (TICD)’ project, five tailored implementation programs to improve healthcare delivery in different chronic conditions have been developed. These programs will be evaluated in distinct cluster-randomized controlled trials. This protocol describes the process evaluation across these trials, which aims to identify determinants of change in chronic illness care, to examine the validity of the tailoring methods that were applied, and to analyze the association of implementation activities and the effectiveness of the program. METHODS: A multilevel approach was used to develop five tailored implementation interventions. In order to guide the process evaluation in five distinct trials, the study protocols for the cluster randomized trials and the related process evaluations were developed simultaneously and iteratively. RESULTS: The process evaluation comprises three main components: a structured survey with health professionals in the trials, semi-structured interviews with a purposeful sample of this study population, and standardized documentation of organizational practice characteristics. Norway will only conduct the qualitative part of the analysis because the survey and documentation of practice characteristics are considered to be not feasible. The evaluation is guided by ‘logic models’ of the implementation programs: frameworks that specify the linkages between the strategies used, the determinants addressed by tailoring, and the anticipated outcomes. Standardization of measures across trials is sought to facilitate analysis of aggregated data from the trials. CONCLUSIONS: This process evaluation will need to find a balance between standardization of methods across trials and the tailoring of measures to the specificities of each trial.
format Online
Article
Text
id pubmed-3994491
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39944912014-04-23 Tailored Implementation for Chronic Diseases (TICD): a protocol for process evaluation in cluster randomized controlled trials in five European countries Jäger, Cornelia Freund, Tobias Steinhäuser, Jost Aakhus, Eivind Flottorp, Signe Godycki-Cwirko, Maciek van Lieshout, Jan Krause, Jane Szecsenyi, Joachim Wensing, Michel Trials Methodology BACKGROUND: In the ‘Tailored Implementation for Chronic Diseases (TICD)’ project, five tailored implementation programs to improve healthcare delivery in different chronic conditions have been developed. These programs will be evaluated in distinct cluster-randomized controlled trials. This protocol describes the process evaluation across these trials, which aims to identify determinants of change in chronic illness care, to examine the validity of the tailoring methods that were applied, and to analyze the association of implementation activities and the effectiveness of the program. METHODS: A multilevel approach was used to develop five tailored implementation interventions. In order to guide the process evaluation in five distinct trials, the study protocols for the cluster randomized trials and the related process evaluations were developed simultaneously and iteratively. RESULTS: The process evaluation comprises three main components: a structured survey with health professionals in the trials, semi-structured interviews with a purposeful sample of this study population, and standardized documentation of organizational practice characteristics. Norway will only conduct the qualitative part of the analysis because the survey and documentation of practice characteristics are considered to be not feasible. The evaluation is guided by ‘logic models’ of the implementation programs: frameworks that specify the linkages between the strategies used, the determinants addressed by tailoring, and the anticipated outcomes. Standardization of measures across trials is sought to facilitate analysis of aggregated data from the trials. CONCLUSIONS: This process evaluation will need to find a balance between standardization of methods across trials and the tailoring of measures to the specificities of each trial. BioMed Central 2014-03-21 /pmc/articles/PMC3994491/ /pubmed/24655439 http://dx.doi.org/10.1186/1745-6215-15-87 Text en Copyright © 2014 Jäger et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Methodology
Jäger, Cornelia
Freund, Tobias
Steinhäuser, Jost
Aakhus, Eivind
Flottorp, Signe
Godycki-Cwirko, Maciek
van Lieshout, Jan
Krause, Jane
Szecsenyi, Joachim
Wensing, Michel
Tailored Implementation for Chronic Diseases (TICD): a protocol for process evaluation in cluster randomized controlled trials in five European countries
title Tailored Implementation for Chronic Diseases (TICD): a protocol for process evaluation in cluster randomized controlled trials in five European countries
title_full Tailored Implementation for Chronic Diseases (TICD): a protocol for process evaluation in cluster randomized controlled trials in five European countries
title_fullStr Tailored Implementation for Chronic Diseases (TICD): a protocol for process evaluation in cluster randomized controlled trials in five European countries
title_full_unstemmed Tailored Implementation for Chronic Diseases (TICD): a protocol for process evaluation in cluster randomized controlled trials in five European countries
title_short Tailored Implementation for Chronic Diseases (TICD): a protocol for process evaluation in cluster randomized controlled trials in five European countries
title_sort tailored implementation for chronic diseases (ticd): a protocol for process evaluation in cluster randomized controlled trials in five european countries
topic Methodology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3994491/
https://www.ncbi.nlm.nih.gov/pubmed/24655439
http://dx.doi.org/10.1186/1745-6215-15-87
work_keys_str_mv AT jagercornelia tailoredimplementationforchronicdiseasesticdaprotocolforprocessevaluationinclusterrandomizedcontrolledtrialsinfiveeuropeancountries
AT freundtobias tailoredimplementationforchronicdiseasesticdaprotocolforprocessevaluationinclusterrandomizedcontrolledtrialsinfiveeuropeancountries
AT steinhauserjost tailoredimplementationforchronicdiseasesticdaprotocolforprocessevaluationinclusterrandomizedcontrolledtrialsinfiveeuropeancountries
AT aakhuseivind tailoredimplementationforchronicdiseasesticdaprotocolforprocessevaluationinclusterrandomizedcontrolledtrialsinfiveeuropeancountries
AT flottorpsigne tailoredimplementationforchronicdiseasesticdaprotocolforprocessevaluationinclusterrandomizedcontrolledtrialsinfiveeuropeancountries
AT godyckicwirkomaciek tailoredimplementationforchronicdiseasesticdaprotocolforprocessevaluationinclusterrandomizedcontrolledtrialsinfiveeuropeancountries
AT vanlieshoutjan tailoredimplementationforchronicdiseasesticdaprotocolforprocessevaluationinclusterrandomizedcontrolledtrialsinfiveeuropeancountries
AT krausejane tailoredimplementationforchronicdiseasesticdaprotocolforprocessevaluationinclusterrandomizedcontrolledtrialsinfiveeuropeancountries
AT szecsenyijoachim tailoredimplementationforchronicdiseasesticdaprotocolforprocessevaluationinclusterrandomizedcontrolledtrialsinfiveeuropeancountries
AT wensingmichel tailoredimplementationforchronicdiseasesticdaprotocolforprocessevaluationinclusterrandomizedcontrolledtrialsinfiveeuropeancountries